Avita Medical (ASX:AVH) signed an exclusive agreement with Revolution Surgical for the distribution of the Recell product platform for thermal burn wound treatment, according to a Wednesday filing with the Australian bourse.
Revolution Surgical will be the exclusive distributor of Recell products in Australia and New Zealand under the deal, the filing said.
Avita Medical shares rose nearly 4% in midday trade Wednesday.
Price (AUD): $3.81, Change: $+0.13, Percent Change: +3.53%